Skip to content
healthcare.dev

ENTECAVIR

NDC 69097-425, ENTECAVIR, tablet, film coated, from Cipla USA Inc..

Product NDC
69097-425
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206872
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-425 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENTECAVIR1 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
69097-425-026909704250230 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-425-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d59e9ea4-09ea-47bd-af2f-39f7a2e2aceb
  • NADAC price for package 69097042502

    GET /v1/drugs/nadac/69097042502

Use it

Look up 69097-425 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-425 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.